These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 890999)

  • 1. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):151-7. PubMed ID: 890999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():55-63. PubMed ID: 354830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract]   [Full Text] [Related]  

  • 4. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
    Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiloride in primary hyperaldosteronism.
    Griffing GT; Cole AG; Aurecchia SA; Sindler BH; Komanicky P; Melby JC
    Clin Pharmacol Ther; 1982 Jan; 31(1):56-61. PubMed ID: 7053305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
    Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1986; 30(2):151-6. PubMed ID: 3519243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiloride in primary hyperaldosteronism with chronic peptic ulceration.
    Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI
    Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total exchangeable potassium in response to amiloride.
    Pearce VR; Antcliff AC; Beevers DG; Hamilton M
    Postgrad Med J; 1978 Aug; 54(634):533-7. PubMed ID: 733684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.
    Nicholls MG; Espiner EA; Hughes H; Rogers T
    Br Heart J; 1976 Oct; 38(10):1025-30. PubMed ID: 973876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amiloride on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in thiazide-treated hypertensive patients.
    Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
    Clin Pharmacol Ther; 1983 Oct; 34(4):448-53. PubMed ID: 6617066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment.
    Eide IK; Torjesen PA; Drolsum A; Babovic A; Lilledahl NP
    J Hypertens; 2004 Nov; 22(11):2217-26. PubMed ID: 15480108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.
    Izzo JL; Hong M; Hussain T; Osmond PJ
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1183-1190. PubMed ID: 31347775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathological basis for a tailored management of essential hypertension].
    Albertazzi A; Del Rosso G; Di Paolo B; Spisni C; Palmieri PF; Cappelli P; Di Vito R
    Clin Ter; 1981 Feb; 96(4):359-69. PubMed ID: 6111413
    [No Abstract]   [Full Text] [Related]  

  • 20. Are idiopathic hyperaldosteronism and low-renin hypertension variants of essential hypertension?
    Brown JJ; Lever AF; Robertson JI; Beevers DG; Cumming AM; Davies DL; Fraser R; Mason P; Morton JJ; Tree M
    Ann Clin Biochem; 1979 Nov; 16(6):380-8. PubMed ID: 395890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.